Purification and Characterization of a Cytosolic, 42-kDa and Ca2+-dependent Phospholipase A2from Bovine Red Blood Cells
ITS INVOLVEMENT IN Ca2+-DEPENDENT RELEASE OF ARACHIDONIC ACID FROM MAMMALIAN RED BLOOD CELLS*
- Hae Sook Shin‡**,
- Mi-Reyoung Chin‡,
- Jung Sun Kim‡,
- Jin-Ho Chung§,
- Chung-Kyu Ryu¶,
- Sung Yun Jung‡ and
- Dae Kyong Kim‡‖
- From the ‡Department of Environmental & Health Chemistry, College of Pharmacy, Chung-Ang University, Dongjak-Ku, Seoul 156-756, the §College of Pharmacy, Seoul National University, Kwanak-Ku, Seoul 151-742, and the ¶Department of Pharmaceutical Analysis, College of Pharmacy, Ewha Womans University, Seodaemun-Ku, Seoul 120-750, South Korea
Abstract
It has become evident that a Ca2+-dependent release of arachidonic acid (AA) and subsequent formation of bioactive lipid mediators such as prostaglandins and leukotrienes in red blood cells (RBCs) can modify physiological functions of neighboring RBCs and platelets. Here we identified a novel type of cytosolic PLA2 in bovine and human RBCs and purified it to apparent homogeneity with a 14,000-fold purification. The purified enzyme, termed rPLA2, has a molecular mass of 42 kDa and reveals biochemical properties similar to group IV cPLA2, but shows different profiles from cPLA2 in several column chromatographies. Moreover, rPLA2 did not react with any of anti-cPLA2 and anti-sPLA2 antibodies and was identified as an unknown protein in matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Divalent metal ions tested exhibited similar effects between rPLA2 and cPLA2, whereas mercurials inhibited cPLA2 but had no effect on rPLA2. Antibody against the 42-kDa protein not only precipitated the rPLA2activity, but also reacted with the 42-kDa protein from bovine and human RBCs in immunoblot analysis. The 42-kDa protein band was selectively detected in murine fetal liver cells known as a type of progenitor cells of RBCs. It was found that EA4, a derivative of quinone newly developed as an inhibitor for rPLA2, inhibited a Ca2+ ionophore-induced AA release from human and bovine RBCs, indicating that this enzyme is responsible for the Ca2+-dependent AA release from mammalian RBCs. Finally, erythroid progenitor cell assay utilizing diaminobenzidine staining of hemoglobinized fetal liver cells showed that rPLA2 detectable in erythroid cells was down-regulated when differentiated to non-erythroid cells. Together, our results suggest that the 42-kDa rPLA2 identified as a novel form of Ca2+-dependent PLA2 may play an important role in hemostasis, thrombosis, and/or erythropoiesis through the Ca2+-dependent release of AA.
- RBCs
- red blood cells
- MFL
- murine fetal liver
- PLA2
- phospholipase A2
- cPLA2
- group IV cytosolic PLA2
- sPLA2
- secretory group II PLA2
- AA
- arachidonic acid
- 2-[1-14C] AA-GPC
- 1-stearoyl-2-[1-14C]arachidonyl-sn-glycerol-3-phosphocholine
- HETE
- hydroxyeicosatetraenoic acid
- rPLA2
- the purified cytosolic RBC PLA2
- MEM
- minimum essential medium
- DAB
- 3,3′-diaminobenzidine
- EPO
- erythropoietin
- MALDI-TOF
- matrix-assisted laser desorption ionization time-of-flight
- HPLC
- high performance liquid chromatography
- FPLC
- fast-protein liquid chromatography
- BSA
- bovine serum albumin
- EA4
- 7-chloro-6-[4-(diethylamino)phenyl]-5,8-quinolinedione
- TP1
- 2-(3,5-di-tert-butyl-4-hydroxyphenyl)-3-chloro-1,4-naphthalene dione
- CFU-E
- colony-forming unit erythroid cells
- Received January 8, 2002.
- Revision received March 13, 2002.
- The American Society for Biochemistry and Molecular Biology, Inc.











